Dive Into Other Topics

Nov 06, 2023

Coherus and Junshi received FDA approval for Loqtorzi, marking significant milestone as first-ever nasopharyngeal carcinoma treatment.

Nov 03, 2023

The dynamics of the Niemann-Pick Disease Type C treatment market are expected to change owing to the emerging therapies by key companies.

Nov 01, 2023

Molecular modeling, a revolutionary branch of science that seeks to understand and manipulate the intricate world of molecules at the atomic and molecular levels, has seen a remarkable transformation in recent years, owing to the growth in technology. The union of computational science, chemistry, and biology has g...

Oct 30, 2023

There are several bone sarcoma types, originating from different cells within bone structure and require specialized diagnosis and treatment

Oct 27, 2023

Future of gene therapies for hemophilia B treatment holds great promise, offering the potential for a paradigm shift in treatment approaches.

Oct 25, 2023

Insulin Pens Market is generating huge demand due to rising prevalence of diabetes. Companies are developing innovative Insulin Pens.

Oct 23, 2023

Following two prior rejections, FDA has granted long-awaited approval to Ardelyx's Xphozah for chronic kidney disease treatment in adults.

Oct 20, 2023

On October 13 2023, the FDA has granted approval for Pfizer’s ulcerative colitis treatment, Etrasimod, under the brand name Velsipity.

Oct 18, 2023

Allergies are on the rise globally, affecting millions of people and significantly impacting their quality of life. The ability to accurately diagnose and manage allergies is crucial for both patients and healthcare providers. With the rising prevalence of allergy, the demand for Allergy Diagnostics has increased m...

Oct 16, 2023

Rare eye diseases can pose burden on patients. Top rare eye diseases are Stargardt Disease, Retinitis Pigmentosa, LHON, Retinoblastoma, LSCD